Linagliptin Improves Glycemic Control in Type 2 Diabetes Patients Inadequately Controlled by Metformin and Sulfonylurea without Weight Gain or Hypoglycemia

被引：0
|
作者：
Owens, David R.
Swallow, Ros
Jones, Peter
Dugi, Klaus A.
Woerle, Hans-Juergen
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A149 / A149
页数：1
相关论文
共 50 条
  • [21] Colesevelam HC1 improves glycemic control in patients with type 2 diabetes inadequately controlled on metformin, sulfonylurea, or insulin-based therapy and treated concomitantly with an ARB or ACE-I
    Chrysant, Steven
    Truitt, Kenneth
    Dmuchowski, Carl
    Jones, Michael
    DIABETES, 2007, 56 : A541 - A541
  • [22] Vildagliptin efficacy and safety in patients with type 2 diabetes inadequately controlled on dual metformin plus sulfonylurea therapy
    Lukashevich, V.
    Wang, M.
    Del Prato, S.
    Araga, M.
    Kothny, W.
    DIABETOLOGIA, 2012, 55 : S353 - S353
  • [23] Saxagliptin added to metformin improves glycemic control in patients with type 2 diabetes
    Defronzo, Ralph A.
    Hissa, Miguel
    Blauwet, Mary Beth
    Chen, Roland S.
    DIABETES, 2007, 56 : A74 - A74
  • [24] Comparison of glycemic variability in type 2 diabetes patients inadequately controlled by metformin combining exenatide or glargine
    Yin, Tingting
    Bi, Yan
    Li, Ping
    Shen, Shanmei
    Wang, Weimin
    Gao, Lijun
    Jiang, Can
    Tao, Junxian
    Wang, Yan
    Zhu, Dalong
    Feng, Wenhuan
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2017, 33
  • [25] Linagliptin improves glycemic control in patients with type 2 diabetes independently of the duration of diabetes and insulin resistance
    Patel, S.
    Weber, S.
    Emser, A.
    von Eynatten, M.
    Woerle, H. -J
    Gibelin, B.
    DIABETES & METABOLISM, 2012, 38 : A97 - A97
  • [26] Metformin improves glycemic control in children with type 2 diabetes
    Jones, K
    Arslanian, S
    McVie, R
    Tomlinson, M
    Park, JS
    DIABETES, 2000, 49 : A75 - A75
  • [27] Exenatide elicits sustained glycaemic control and progressive reduction of body weight in patients with type 2 diabetes inadequately controlled by sulphonylureas with or without metformin
    Riddle, Matthew C.
    Henry, Robert R.
    Poon, Terri H.
    Zhang, Bei
    Mac, Susanna M.
    Holcombe, John H.
    Kim, Dennis D.
    Maggs, David G.
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2006, 22 (06) : 483 - 491
  • [28] Efficacy and safety of 5 mg daily dosing regimens with linagliptin in patients with type 2 diabetes inadequately controlled on metformin
    Rafeiro, E.
    Ross, S. A.
    Meinicke, T.
    Toorawa, R.
    Woerle, H. -J.
    DIABETOLOGIA, 2011, 54 : S338 - S339
  • [29] LINAGLIPTIN IMPROVES GLYCEMIC CONTROL INDEPENDENT OF BODY MASS INDEX IN PATIENTS WITH TYPE 2 DIABETES
    Rendell, Marc
    Chrysant, Steven
    Trujillo, Angelina
    Emser, Angela
    von Eynatten, Maximilian
    Patel, Sanjay
    Woerle, Hans-Juergen
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2011, 26 : S214 - S215
  • [30] Treatment intensification with insulin glargine in patients with inadequately controlled type 2 diabetes improves glycaemic control with a high treatment satisfaction and no weight gain
    Riebenfeld, Daniela
    Spirk, David
    Mathis, Alexandra
    Villiger, Lukas
    Gerber, Philipp A.
    Gasser, Urs Erwin
    Lehmann, Roger
    SWISS MEDICAL WEEKLY, 2015, 145
12345